SPRO
Spero Therapeutics Inc.
$2.00
$0.00(0.00%)
44
Overall
--
Value
45
Tech
44
Quality
Market Cap
$106.92M
Volume
393.62K
52W Range
$0.51 - $3.22
Target Price
$5.00
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Total Revenue | $2.0M | $4.0M | $18.1M | $9.3M | $18.3M | $53.5M | $933.0K | $371.0K | ||
| Total Revenue | $2.0M | $4.0M | $4.7M | $258.0K | $3.1M | $48.6M | $103.8M | $48.0M | ||
| GROSS PROFIT | ||||||||||
| Gross Profit | $2.0M | $4.0M | $18.1M | $9.3M | $18.3M | $53.5M | $103.8M | $48.0M | ||
| OPERATING EXPENSES | ||||||||||
| Operating Expenses | $-43.7M | $-46.8M | $-81.4M | $88.4M | $106.2M | $79.1M | $82.3M | $121.3M | ||
| Research & Development | $32.9M | $33.9M | $65.8M | $67.0M | $64.5M | $47.6M | $51.4M | $96.8M | ||
| Research Expense | $32.9M | $33.9M | $65.8M | $67.0M | $64.5M | $47.6M | $51.4M | $96.8M | ||
| Selling, General & Administrative | $10.8M | $12.9M | $15.6M | $21.4M | $41.7M | $36.5M | $25.6M | $23.7M | ||
| General & Administrative Expenses | $10.8M | $12.9M | $15.6M | $21.4M | $41.7M | $36.5M | $25.6M | $23.7M | ||
| Salaries & Wages | $-1.4M | $-2.7M | $-3.8M | $4.9M | $9.4M | $9.1M | $7.9M | $7.8M | ||
| Depreciation & Amortization | $-363.0K | $-409.0K | $-750.0K | $761.0K | $646.0K | $869.0K | $367.0K | $2.0K | ||
| Depreciation & Amortization | $-363.0K | $-409.0K | $-750.0K | $761.0K | $646.0K | $869.0K | $367.0K | $2.0K | ||
| Other Operating Expenses | $-43.7M | $-46.8M | $-81.4M | $1.4M | $1.8M | $1.7M | $1.6M | $1.6M | ||
| OPERATING INCOME | ||||||||||
| Operating income | $-41.7M | $-42.8M | $-63.2M | $-79.1M | $-88.0M | $-42.2M | $21.5M | $-73.4M | ||
| EBITDA | $-39.5M | $-41.9M | $-60.9M | $-77.5M | $-87.2M | $-42.9M | $25.8M | $-68.6M | ||
| NON-OPERATING ITEMS | ||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $1.9M | $2.6M | -- | -- | ||
| Intinc | $303.0K | $1.1M | $1.3M | $401.0K | $346.0K | $1.1M | $3.9M | $4.7M | ||
| Net Non-Operating Interest Income/Expense | $303.0K | $1.1M | $1.3M | $401.0K | $346.0K | $1.5M | $3.9M | $4.7M | ||
| Gain on Sale of Securities | -- | -- | $223.0K | -- | $204.0K | $917.0K | -- | -- | ||
| Other Income/Expense | $-1.5M | $-43.0K | $-963.0K | $-432.0K | $2.1M | $-14.3M | $14.0K | $-60.0K | ||
| Other Special Charges | $1.5M | $43.0K | $740.0K | $432.0K | $-2.3M | $-6.2M | $-14.0K | $60.0K | ||
| SPECIAL ITEMS | ||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $11.6M | -- | $877.0K | ||
| Special Income Charges | -- | -- | -- | -- | -- | $-12.3M | $-5.3M | $-877.0K | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $635.0K | $5.3M | -- | ||
| PRE-TAX INCOME | ||||||||||
| EBIT | $-39.9M | $-41.7M | $-60.9M | $-78.3M | $-87.8M | $-43.8M | $25.4M | $-68.6M | ||
| Pre-Tax Income | $-39.9M | $-41.7M | $-60.9M | $-78.3M | $-89.8M | $-46.4M | $-77.4M | $-116.2M | ||
| INCOME TAX | ||||||||||
| Tax Provision | -- | -- | -- | -- | -- | -- | $2.6M | -- | ||
| NET INCOME | ||||||||||
| Net Income | $-38.7M | $-41.7M | $-60.9M | $-78.3M | $-89.8M | $-46.4M | $22.8M | $-68.6M | ||
| Net Income (Continuing Operations) | $-38.7M | $-41.7M | $-60.9M | $-78.3M | $-89.8M | $-46.4M | $22.8M | $-68.6M | ||
| Net Income (Discontinued Operations) | $-38.7M | $-41.7M | $-60.9M | $-78.3M | $-89.8M | $-46.4M | $22.8M | $-68.6M | ||
| Net Income (Common Stockholders) | $-46.1M | $-41.7M | $-60.9M | $-78.3M | $-89.8M | $-46.4M | $22.8M | $-68.6M | ||
| Normalized Income | -- | -- | -- | -- | $-70.9M | -- | -- | $-114.1M | ||
| TOTALS | ||||||||||
| Total Expenses | $-43.7M | $-46.8M | $-81.4M | $88.4M | $106.2M | $79.1M | $82.3M | $121.3M | ||
| SHARE & EPS DATA | ||||||||||
| Average Shares Outstanding | $2.6M | $16.0M | $18.2M | $22.4M | $30.9M | $37.6M | $52.7M | $54.0M | ||
| Average Shares Outstanding (Diluted) | $2.2M | $16.0M | $18.2M | $22.4M | -- | $37.6M | $53.0M | $54.0M | ||
| Shares Outstanding | $14.4M | $17.2M | $20.3M | $29.5M | $32.8M | $52.6M | $53.9M | $55.9M | ||
| Basic EPS | -- | -- | -- | $-3.52 | $-2.91 | $-1.23 | $0.43 | $-1.27 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-3.52 | $-2.91 | $-1.23 | $0.43 | $-1.27 | ||
| Diluted EPS | $-17.82 | $-2.6 | $-3.35 | $-3.52 | $-2.91 | $-1.23 | $0.43 | $-1.27 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-1.23 | $0.43 | $-1.27 | ||
| OTHER METRICS | ||||||||||
| Accrued Preferred Stock Dividends | $7.4M | -- | -- | $549.0K | -- | -- | -- | -- | ||
| Minority Interests | $1.1M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $10.8M | $12.9M | $15.6M | $21.4M | $41.7M | $36.5M | $25.6M | $23.7M | ||
| Otherunder Preferred Stock Dividend | $7.4M | -- | -- | $549.0K | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $7.4M | -- | -- | $549.0K | -- | -- | -- | -- | ||
| Rent And Landing Fees | $10.8M | $12.9M | $15.6M | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | $11.6M | -- | $877.0K | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SPRO | $2.00 | 0% | 393.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |